Innate Pharma SA (NAS:IPHA)
$ 1.9 0.05 (2.7%) Market Cap: 153.81 Mil Enterprise Value: 93.89 Mil PE Ratio: 0 PB Ratio: 4.75 GF Score: 56/100

Q2 2021 Innate Pharma SA Earnings Call Transcript

Sep 15, 2021 / 12:00PM GMT
Release Date Price: $5.58 (+2.01%)
Operator

Good day, and thank you for standing by, and welcome to the Innate Pharma half year results conference call. (Operator Instructions)

Now I would like to hand the conference over to your speaker, Mondher Mahjoubi. Please go ahead.

Mondher Mahjoubi
Innate Pharma S.A. - Chairman of Executive Board & CEO

Thank you. Good morning. Good afternoon, and welcome everyone. Really, pleasure to be here with you today. This morning, we issued a press release providing a business update for the first half of 2021. I look forward to explaining the progress we've made during the year-to-date as well as address some future goals and milestones. The press release and today's presentation are both available on the IR section of our website.

And before we start on Slide 2, I would like to remind you that we'll make forward-looking statements regarding the financial outlook in addition to regulatory and product plan development. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted.

On

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot